Form 8-K - Current report:
SEC Accession No. 0001520138-18-000272
Filing Date
2018-10-09
Accepted
2018-10-05 18:32:43
Documents
1
Period of Report
2018-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT biovie-20181001_8k.htm 8-K 18408
  Complete submission text file 0001520138-18-000272.txt   19718
Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55292 | Film No.: 181111554
SIC: 2834 Pharmaceutical Preparations